Our ‘Research In Practice’ profiles bring you original content - from interviews and posts, to exciting and interactive live events focused on latest trends and findings in translational medicine.
This September, ‘Research in Practice in Cancer’ presents a 3-part series on ‘T Cells and Cancer’. Join our third episode on 3rd November at 10am BST / GMT with Dr Ben Draper, UCL. Sign up here to receive email reminders for this series.
What are we going to talk about in this episode?
The talk will mainly centre around current strategies to overcome the barriers that have emerged for treating solid tumours with immunotherapies, in particular adoptive cell transfer.
- 2nd September, 10am BST / 9am GMT - ‘T cell immunological research at the forefront of defeating cancer’ with Dr Vivian Dimou, The Institute of Cancer Research
- 13th September, 1pm BST / 12 pm GMT - ‘Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors’ with Prof Karine Breckpot Vrije Universiteit Brussel
- 3rd November, 10am BST / GMT - ‘Engineering T-cells for the Treatment of Solid Tumours’ with Dr Ben Draper, UCL
Please follow Researcher Live’s profile ‘Research In Practice in Cancer’ for interview content, relevant posts, and future event series!
If you'd like to present at your own Researcher Live event, please email email@example.com
10:00 am GMT+0
Ben started working on CAR T-cells during his MSc project in Dr. Martin Pules' Lab. He then worked with Dr. Pule on BCMA-targeted CARs for treating myeloma and was partially involved in developing a spin-out company, Autolus. He then moved to Dr. John Maher's lab at King's College London where he focused more on CARs for treating solid-tumours and gained experience in gamma-delta T-cells. He completed his PhD with Dr. Maher on improving CAR T-cell design for treating Head and Neck Cancer and Glioblastoma.
During his PhD he was also involved in spinning out a company from Dr. Maher's lab, Leucid Bio. He then moved to Dr. Laura Donovan's lab as a Postdoctoral Fellow at the Institute of Child Health at UCL where he currently works on developing CAR T-cells for treating medulloblastoma, as well as investigating the underlying biology behind tumours that become resistant to treatment.
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.